FDA Adverse Event Malfunction Summary report: N

BD BBL¿ MIDDLEBROOK AND COHN 7H10 AGAR SLANTS

MDR report key: 15166977 · Received August 4, 2022

Report

Report Number
1119779-2022-01066
Event Type
Malfunction
Date Received
August 4, 2022
Date of Event
July 11, 2022
Report Date
September 18, 2022
Manufacturer
BECTON, DICKINSON & CO. (SPARKS)
Product Code
JSJ
UDI-DI
30382902209585
PMA / PMN Number
PREAMENDMENT
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
UK
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

A DEVICE EVALUATION IS ANTICIPATED BUT HAS NOT YET BEGUN. UPON COMPLETION OF THE INVESTIGATION, A SUPPLEMENTAL REPORT WILL BE FILED.

Additional Manufacturer Narrative · 0

H.6 INVESTIGATION SUMMARY: MATERIAL 220958 IS MANUFACTURED BY REHYDRATING THE MEDIA COMPONENTS WITH USP PURIFIED WATER AND THOROUGHLY MIXING UNTIL A HOMOGENEOUS SOLUTION IS OBTAINED. THE MEDIA IS THEN HEAT PROCESSED WITHIN A STERILIZATION MODULE PER STANDARD OPERATING PROCEDURE (SOP). HEAT SENSITIVE COMPONENTS ARE ADDED DURING FILLING. FILLING, CAPPING AND TORQUEING ARE PERFORMED WITHIN THE ASEPTIC PROCESSING AREA MECHANICALLY. ONCE THE SLANTS HAVE SOLIDIFIED, THE TUBES ARE THEN LABELED IN A SEPARATE PACKAGING AREA. THE BATCH HISTORY RECORD REVIEW FOR BATCH 1182157 WAS SATISFACTORY AND NO NOTIFICATIONS WERE GENERATED DURING MANUFACTURING AND INSPECTION. FORMULATION AND FILLING PROCESSES WERE WITHIN SPECIFICATIONS. QC INSPECTION AND TESTING WERE SATISFACTORY AT TIME OF RELEASE. THE RELEASE TESTING THAT IS PERFORMED ON THIS PRODUCT DOES INCLUDE BIOBURDEN TESTING. SAMPLES ARE INCUBATED AT 25 DEGREES C AND AT 35 DEGREES C FOR 28 DAYS. ALL BIOBURDEN TESTING PERFORMED ON THIS BATCH WAS SATISFACTORY PER OUR INTERNAL PROCEDURES. THE COMPLAINT HISTORY WAS REVIEWED, AND NO OTHER COMPLAINTS HAVE BEEN TAKEN ON THIS BATCH. RETENTION SAMPLES FROM BATCH 1182157 (10 TUBES) WERE AVAILABLE FOR INVESTIGATION. NO SUBSURFACE PARTICLES OR MICROBIAL GROWTH WAS OBSERVED IN 10/10 RETENTION SAMPLES. FOR INVESTIGATION OF THE COMPLAINT, THE RETENTIONS WERE INCUBATED FOR A 21-DAY INCUBATION PERIOD WITH THE CAPS LOOSENED. ONE RETENTION TUBE WAS PLACED INTO 33-37-DEGREE INCUBATION, AND ONE TUBE WAS PLACED INTO 20-25-DEGREE INCUBATION. NO MICROBIAL GROWTH OR SUB SURFACE PARTICLES WERE OBSERVED AFTER INCUBATION IN 2/2 RETENTION SAMPLES. NO PHOTOS WERE RECEIVED TO ASSIST WITH THE INVESTIGATION. NO RETURNS WERE RECEIVED TO ASSIST WITH THE INVESTIGATION. THIS COMPLAINT CANNOT BE CONFIRMED. BD WILL CONTINUE TO TREND COMPLAINTS FOR CONTAMINATION. COMPONENTS ARE PREPARED, COMBINED, AND DISPENSED ASEPTICALLY BUT THERE IS NO FINAL STERILIZATION STEP AFTER DISPENSING. THE MANUFACTURING PROCESS HAS BEEN DESIGNED TO MINIMIZE BIOBURDEN AND QC INSPECTION INCLUDES BIOBURDEN TESTING PRIOR TO RELEASE. ADDITIONALLY, IN-PROCESS INSPECTIONS ARE CONDUCTED DURING MANUFACTURING, AND PARTICLES OR FOREIGN MATERIALS ARE TO BE REJECTED PER PROCEDURES. HOWEVER, THERE IS NO GUARANTEE THAT THE END USER WILL NOT RECEIVE A CONTAMINATED TUBE OR THAT ALL TUBES WILL BE FREE OF DEFECTS. H3 OTHER TEXT : SEE H.10.

Description of Event or Problem · 0

IT WAS REPORTED THAT BD BBL¿ MIDDLEBROOK AND COHN 7H10 AGAR SLANTS WERE CONTAMINATED. THERE WAS NO REPORT OF PATIENT IMPACT. ONE SLANT WAS AFFECTED. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: IT WAS REPORTED BY THE CUSTOMER THAT THERE WAS "A CONTAMINATED AGAR SLANT."

Description of Event or Problem · 0

IT WAS REPORTED THAT BD BBL¿ MIDDLEBROOK AND COHN 7H10 AGAR SLANTS WERE CONTAMINATED. THERE WAS NO REPORT OF PATIENT IMPACT. ONE SLANT WAS AFFECTED. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: IT WAS REPORTED BY THE CUSTOMER THAT THERE WAS "A CONTAMINATED AGAR SLANT."

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2133857 BD BBL¿ MIDDLEBROOK AND COHN 7H10 AGAR SLANTS CULTURE MEDIA, SELECTIVE AND NON-DIFFERENTIAL JSJ BECTON, DICKINSON & CO. (SPARKS) 220958 1182157 30382902209585

Patients

Seq Age Sex Outcome Treatment
1 Unknown